Skip to main content
Clinical Trials/NCT02199132
NCT02199132
Completed
Not Applicable

Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli

Corporacion Parc Tauli1 site in 1 country50 target enrollmentJuly 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nasopharyngeal Carcinoma
Sponsor
Corporacion Parc Tauli
Enrollment
50
Locations
1
Primary Endpoint
Description of Nasopharyngeal Carcinoma Patients
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Retrospective study of patients diagnosed with a nasopharyngeal carcinoma included in our data base care between June 1990 and September 2013.

Our hypothesis is:

Our series of patients with a history of nasopharyngeal carcinoma presents epidemiological, response rates to the different treatments and survival similar to those described in the literature

Detailed Description

Retrospective study of 50 patients diagnosed with nasopharyngeal carcinoma. The following variables will be studied: age, sex, toxic habits , associated pathology, patient origin , first symptom , duration , histology, stage , second malignancies , recurrences , metastases , treatments performed , the response thereto and survival.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
October 2014
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Corporacion Parc Tauli
Responsible Party
Principal Investigator
Principal Investigator

Yolanda Escamilla-Carpintero

MD Phd

Corporacion Parc Tauli

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed of Nasopharyngeal Carcinoma at Ear-Nose-Throat Department at Corporació Sanitària Parc Taulí from 1993 to 2013

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Description of Nasopharyngeal Carcinoma Patients

Time Frame: 1 year after diagnostic

Describe our population diagnosed nasopharyngeal carcinoma and compared in epidemiology and therapeutic results with those in the literature

Study Sites (1)

Loading locations...

Similar Trials